P/E ratio for Agios Pharmaceuticals (AGIO)

P/E ratio history for Agios Pharmaceuticals from 2013 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Xencor XNCR	-7.18	-17.25%	🇺🇸 USA
Exelixis EXEL	135	-1,657.89%	🇺🇸 USA
Pfizer PFE	14.0	-261.51%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	89.9	-1,136.03%	🇺🇸 USA
GlaxoSmithKline GSK	10.6	-222.57%	🇬🇧 UK
Eli Lilly LLY	166	-2,019.40%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.